Natasha Persaud

In a study, diabetes increased the odds of pathologic upgrading of renal cell carcinoma by 65% and 32%, among patients undergoing partial and radical nephrectomy, respectively.

PSMA PET/CT appears highly likely to identify and stage prostate cancer in patients at least 80 years old with a PSA level of at least 20 ng/mL, even without biopsy confirmation, according to investigators.

Investigators compared ADT plus abiraterone or docetaxel with ADT alone.

Patients with prostate cancer who have visceral metastases limited to the lung have the best prognosis.

Neoadjuvant immunotherapy is an attractive alternative to chemotherapy for patients with localized MIBC because of its lower toxicity profile.

Patient comorbidities were among the significant risk factors for kidney function decline.

Whether the center was an academic setting or not had no bearing on results.

This HRQoL analysis can help inform discussions of the benefit-risk profile of olaparib plus abiraterone.

According to investigators, the totality of the data support the potential clinical utility of 18F-rhPSMA-7.3.

Emerging evidence links bladder cancer to pelvic radiation therapy, dietary factors, and gene-environment interactions.